Mion F, Cloix P, Boillot O, Gille D, Bouvier R, Paliard P, Berger F
Unité de Transplantation Hépatique, Hôpital Edouard-Herriot, Lyon.
Gastroenterol Clin Biol. 1993;17(11):863-7.
Azathioprine vascular hepatotoxicity has been described mainly after renal transplantation. We report a new case in a patient who developed veno-occlusive disease of the liver 3 weeks after liver transplantation; regression of lesions were observed after discontinuation of azathioprine therapy. In this case, azathioprine hepatotoxicity may have been enhanced by a previous episode of severe, acute rejection prevailing in the hepatic veins. After liver transplantation, the diagnosis of azathioprine hepatotoxicity is difficult but should be suspected in the presence of non-inflammatory small hepatic veins lesions. Early withdrawal of the drug is mandatory for complete recovery.
硫唑嘌呤血管性肝毒性主要在肾移植后被描述。我们报告了一例新病例,该患者在肝移植后3周发生肝静脉闭塞性疾病;停用硫唑嘌呤治疗后观察到病变消退。在该病例中,硫唑嘌呤肝毒性可能因先前肝静脉中严重急性排斥反应的发作而增强。肝移植后,硫唑嘌呤肝毒性的诊断困难,但在存在非炎性小肝静脉病变时应怀疑。为了完全康复,必须尽早停用该药物。